NYLIM
AERI

New York Life Investment Management’s Aerie Pharmaceuticals AERI Stock Holding History

New York Life Investment Management’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-519,661
Closed -$7.86M – 1216
2022
Q3 		$7.86M Buy
519,661
+468,415
+914% +$5.44M 0.1% 226
2022
Q2 		$384K Buy
+51,246
New +$361K ﹤0.01% 1014

New York Life Investment Management's AERI Position: Q4 2022 in Review

New York Life Investment Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 519,661 shares — an estimated $7.86M sold.

New York Life Investment Management first reported a position in AERI in Q2 2022 and held it in 2 quarters. The position peaked at $7.86M in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • New York Life Investment Management reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • New York Life Investment Management sold 519,661 Aerie Pharmaceuticals shares in Q4 2022, an estimated $7.86M.
  • New York Life Investment Management first reported a position in Aerie Pharmaceuticals in Q2 2022 and held it in 2 quarters.
  • New York Life Investment Management's Aerie Pharmaceuticals position peaked at $7.86M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on New York Life Investment Management's 13F filing for Q4 2022, filed 10 Feb 2023.